Related Experiment Video
Updated: May 2, 2026

A Proximal Culture Method to Study Paracrine Signaling Between Cells
Published on: August 28, 2018
Estrogen signaling crosstalk: Implications for endocrine resistance in ovarian cancer
Jennifer R Ribeiro1, Richard N Freiman2
1Brown University, Pathobiology Graduate Program, 70 Ship St., Providence, RI 02903, USA.
Abstract:
Resistance to anti-estrogen therapies is a prominent challenge in the treatment of ovarian cancer. Tumors develop endocrine resistance by acquiring adaptations that help them rely on alternative oncogenic signaling cascades, which crosstalk with estrogen signaling pathways. An understanding of estrogen signaling crosstalk with these growth promoting cascades is essential in order to maximize efficacy of anti-estrogen treatments in ovarian cancer. Herein, we provide an overview of estrogen signaling in ovarian cancer and discuss the major challenges associated with anti-estrogen therapies. We also review what is currently known about how genomic and non-genomic estrogen signaling pathways crosstalk with several major oncogenic signaling cascades. The insights provided here illustrate existing strategies for targeting endocrine resistant ovarian tumors and may help identify new strategies to improve the treatment of this disease.
Insights
Ovarian cancer resistance to anti-estrogen therapies is a major challenge. Understanding estrogen signaling crosstalk with oncogenic pathways is key to improving treatments for endocrine-resistant ovarian tumors.
Area of Science:
- Oncology
- Endocrinology
- Molecular Biology
Background:
- Anti-estrogen therapies are crucial for ovarian cancer treatment.
- Endocrine resistance in ovarian tumors limits treatment efficacy.
- Tumors adapt by utilizing alternative oncogenic signaling pathways that interact with estrogen signaling.
Purpose of the Study:
- To provide an overview of estrogen signaling in ovarian cancer.
- To discuss challenges in anti-estrogen therapies.
- To review crosstalk between estrogen signaling and oncogenic cascades.
Main Methods:
- Literature review of estrogen signaling pathways.
- Analysis of genomic and non-genomic estrogen signaling.
- Examination of crosstalk with major oncogenic signaling cascades.
Main Results:
- Estrogen signaling plays a complex role in ovarian cancer.
- Crosstalk with oncogenic pathways contributes to endocrine resistance.
- Genomic and non-genomic pathways exhibit significant interactions.
Conclusions:
- Understanding estrogen signaling crosstalk is essential for overcoming resistance.
- Current strategies target endocrine-resistant ovarian tumors.
- New therapeutic strategies may emerge from insights into signaling crosstalk.
Related Concept Videos
Oogenesis
Endocrine Signaling
Endocrine Signaling
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Autocrine Signaling
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
Treatment Resistant Cancers

